Yutaka Aritomi

Randomized, double‐blind, placebo‐controlled 8‐week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder

Akira Nishimura, Yutaka Aritomi, Kiyofumi Sasai et al. · Psychiatry and Clinical Neurosciences · 2017 · 46 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Pharmacokinetics, Safety, and Tolerability of Vortioxetine Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Adults

Kumi Matsuno, Koki Nakamura, Yutaka Aritomi et al. · Clinical Pharmacology in Drug Development · 2017 · 15 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Characterization of <i>APOE</i> and <i>TOMM40</i> allele frequencies in the Japanese population

Akira Nishimura, Hidenori Nonomura, Shingo Tanaka et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2017 · 13 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17